Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Phase 3

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Propofol+ Rocuronium+ Fentanyl + Inhalational
Drug: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
Procedure: Open Pancreaticoduodenectomy

First Posted Date: 2018-02-15

Last Posted Date: 2024-07-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 133

Registration Number: NCT03434678

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Consent only), Commack, New York, United States

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Active, not recruiting

Conditions: Colon Cancer
Liver Tumors

Interventions: Other: blood draws
Procedure: colectomy or hepatectomy
Diagnostic Test: Fibroscan test

First Posted Date: 2018-02-14

Last Posted Date: 2024-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT03432806

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 1 locations

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Phase 2

Completed

Conditions: Non-Transitional Cell Carcinoma of the Urothelial Tract
Small Cell of the Bladder
Squamous Cell Carcinoma of the Bladder
Metastatic Bladder Cancer
Adenocarcinoma of the Bladder

Interventions: Drug: durvalumab and tremelimumab

First Posted Date: 2018-02-13

Last Posted Date: 2021-12-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT03430895

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography

Completed

Conditions: Anesthesia

Interventions: Other: Blind Gastric Tube Placement

First Posted Date: 2018-02-13

Last Posted Date: 2019-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 166

Registration Number: NCT03430908

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active, not recruiting

Conditions: Breast Cancer

Interventions: Behavioral: Harvard Health Professionals survey
Procedure: Research Tissue sampling
Other: Blood draw
Other: CPET Procedures
Other: stool sample

First Posted Date: 2018-02-07

Last Posted Date: 2024-08-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT03424915

Locations: 🇺🇸
Memorial Sloan Kettering Commack (Consent and Follow-up), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent and Follow-up), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Consent and Follow-up), New York, New York, United States

and more 4 locations

Treating Patients With Melanoma and ALK Alterations With Ensartinib

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Ensartinib
Diagnostic Test: ALKATI by Customized Nanostring Assay

First Posted Date: 2018-02-05

Last Posted Date: 2024-02-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03420508

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Phase 2

Active, not recruiting

Conditions: Sarcoma

Interventions: Drug: Epacadostat
Drug: Pembrolizumab

First Posted Date: 2018-01-29

Last Posted Date: 2024-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT03414229

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia

Phase 2

Active, not recruiting

Conditions: Hairy Cell Leukemia
Leukemia
Leukemia, Hairy Cell

Interventions: Drug: Vemurafenib
Drug: Obinutuzumab

First Posted Date: 2018-01-25

Last Posted Date: 2024-12-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT03410875

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 6 locations

A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure

Not Applicable

Completed

Conditions: Laparotomy

Interventions: Procedure: Laparotomy
Other: ICG
Other: Spectrum NIR imaging system

First Posted Date: 2018-01-24

Last Posted Date: 2022-08-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT03408366

Locations: 🇺🇸
Memoral Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States

and more 5 locations

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Phase 1

Completed

Conditions: Malignant Mesothelioma (MPM)

Interventions: Drug: Avelumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2018-01-16

Last Posted Date: 2023-10-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT03399552

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy